Hiral Jani, PA-C Physician Assistant Medicare: Medicare Enrolled Practice Location: 561 Middlesex Ave, Metuchen, NJ 08840 Phone: 732-549-9363 |
Maya Kalina Inman, Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 68 Brunswick Ave, Metuchen, NJ 08840 Phone: 732-947-8724 |
Mrs. Elizabeth Anne Freis-blom, PA-C Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 443 Middlesex Ave, Metuchen, NJ 08840 Phone: 732-548-5991 |
Monica Gad, PA Physician Assistant - Medical Medicare: Accepting Medicare Assignments Practice Location: 561 Middlesex Ave, Metuchen, NJ 08840 Phone: 732-549-9363 |
Shahenaz Halani, PA Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 18 Mark Cir, Metuchen, NJ 08840 Phone: 732-261-5575 |
News Archive
Momenta Pharmaceuticals, Inc., a biotechnology company specializing in the characterization and engineering of complex drugs, today announced the pricing of an underwritten public offering of 4,000,000 shares of its common stock at $14.35 per share. The total proceeds, before expenses, to Momenta will be approximately $57.4 million. The offering is expected to close on December 13, 2010, subject to customary closing conditions.
Lentigen Corporation, a biotechnology company specializing in the development and manufacture of lentiviral gene delivery technologies, announced today that it has received a National Institutes of Health (NIH) small business technology transfer (STTR) grant for a program on "Lentiviral Gene Therapy for Mucopolysaccharidosis."
A study conducted by Sarah Farabi, PhD, RN, while she was a post-doctoral fellow working with Dr. Teri Hernandez at the University of Colorado College of Nursing and School of Medicine in 2018 found that mild sleep apnea changed sugar levels during pregnancy and was connected to infant growth patterns related to increased risk of obesity.
African American women with early stage, invasive breast cancer were 12 percent less likely than Caucasian women with the same diagnosis to receive a minimally invasive technique, axillary sentinel lymph node (SLN) biopsy, even as the procedure had become the standard of surgical practice, according to research from The University of Texas MD Anderson Cancer Center.
› Verified 2 days ago